Seroatlas · Human Serome Atlas

RRM2B

Ribonucleoside-diphosphate reductase subunit M2 B

Also known as: p53R2, RIR2B_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q7LG56
Gene
RRM2B
Ensembl
ENSG00000048392
Chromosome
8
Canonical length
351 aa
Protein class
Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
Subcellular location
Nucleoplasm,Cytosol

OverviewNCBI Gene

This gene encodes the small subunit of a p53-inducible ribonucleotide reductase. This heterotetrameric enzyme catalyzes the conversion of ribonucleoside diphosphates to deoxyribonucleoside diphosphates. The product of this reaction is necessary for DNA synthesis. Mutations in this gene have been associated with autosomal recessive mitochondrial DNA depletion syndrome, autosomal dominant progressive external ophthalmoplegia-5, and mitochondrial neurogastrointestinal encephalopathy. Alternatively spliced transcript variants have been described.[provided by RefSeq, Feb 2010]

Canonical amino-acid sequenceUniProt

351 residues, UniProt reviewed canonical sequence.

>Q7LG56|RRM2B
     1  MGDPERPEAA GLDQDERSSS DTNESEIKSN EEPLLRKSSR RFVIFPIQYP DIWKMYKQAQ
    61  ASFWTAEEVD LSKDLPHWNK LKADEKYFIS HILAFFAASD GIVNENLVER FSQEVQVPEA
   121  RCFYGFQILI ENVHSEMYSL LIDTYIRDPK KREFLFNAIE TMPYVKKKAD WALRWIADRK
   181  STFGERVVAF AAVEGVFFSG SFAAIFWLKK RGLMPGLTFS NELISRDEGL HCDFACLMFQ
   241  YLVNKPSEER VREIIVDAVK IEQEFLTEAL PVGLIGMNCI LMKQYIEFVA DRLLVELGFS
   301  KVFQAENPFD FMENISLEGK TNFFEKRVSE YQRFAVMAET TDNVFTLDAD F

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against RRM2B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.28
Highest tissue expression
42 nTPM

Expression across tissuesHPA

Tissue

  • parathyroid gland: 42 nTPM
  • thyroid gland: 37 nTPM
  • tongue: 33 nTPM
  • skeletal muscle: 29 nTPM
  • kidney: 23 nTPM
  • choroid plexus: 23 nTPM

Single-cell type

  • thymic myoid cells: 186 nCPM
  • neutrophils: 142 nCPM
  • fallopian tube ciliated cells: 92 nCPM
  • respiratory ciliated cells: 82 nCPM
  • endometrial ciliated cells: 69 nCPM
  • neutrophil progenitors: 66 nCPM

Immune cell

  • neutrophil: 23 nTPM
  • basophil: 16 nTPM
  • non-classical monocyte: 12 nTPM
  • naive B-cell: 8.6 nTPM
  • myeloid DC: 7.7 nTPM
  • eosinophil: 7 nTPM

Brain region

  • choroid plexus: 52 nTPM
  • white matter: 31 nTPM
  • spinal cord: 26 nTPM
  • medulla oblongata: 26 nTPM
  • hypothalamus: 25 nTPM
  • pons: 25 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about RRM2B.

Disease | AllUniProt

Conditions RRM2B is implicated in, by any mechanism.

Disease | GeneticClinVar

45 pathogenic / likely-pathogenic of 463 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.7
gnomAD pLI
0
gnomAD missense Z
1.21
DepMap mean gene effect
0
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of RRM2B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads RRM2B as an antibody target. Whether an autoantibody or antibody against RRM2B could matter depends on whether native RRM2B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

RRM2B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label RRM2B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/RRM2B. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...